(Q42288252)

19 October 2017

Targeted delivery of siRNA against hepatitis B virus by preS1 peptide molecular ligand (English)

1 reference

19 October 2017

1 reference

Wenjuan Huang

1

1 reference

19 October 2017

Xia Li

2

1 reference

19 October 2017

Min Yi

3

1 reference

19 October 2017

Sufen Zhu

4

1 reference

19 October 2017

Weixian Chen

5

1 reference

19 October 2017

21 July 2013

1 reference

19 October 2017

1 reference

19 October 2017

44

1 reference

19 October 2017

8

1 reference

19 October 2017

897-906

1 reference

Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures

19 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Hepatitis B virus is inhibited by RNA interference in cell culture and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Increased virus replication in mammalian cells by blocking intracellular innate defense responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Small interfering RNA-based molecular therapy of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Receptor for pre-S1(21-47) component of hepatitis B virus on the liver cell: role in virus cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Enhancement of hepatitis B virus replication by androgen and its receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

High-density lipoprotein facilitates in vivo delivery of α-tocopherol-conjugated short-interfering RNA to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Targeted delivery of siRNA into breast cancer cells via phage fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Arg9-peptide facilitates the internalization of an anti-CEA immunotoxin and potentiates its specific cytotoxicity to target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Pyrenebutyrate Leads to Cellular Binding, Not Intracellular Delivery, of Polyarginine-Quantum Dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Replication of clinical hepatitis B virus isolate and its application for selecting antiviral agents for chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

Animal models for the study of HBV replication and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12189

21 January 2018

Identifiers

DOI

10.1111/HEPR.12189

1 reference

19 October 2017

1 reference